PaySauce (PYS) Q1 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 TU earnings summary
13 Jun, 2025Executive summary
Achieved 18% year-over-year growth in ARR to $8.2m and 20% growth in recurring revenue to $2.1m for Q1 FY25.
Completed Proof of Concept for wholesale payroll using the new Gen 2.0 engine, marking a pivotal milestone for future growth.
Customer base grew 7% year-over-year to 7,611, with targeted sales and marketing efforts in new verticals and regions.
Financial highlights
Recurring revenue for Q1 FY25 reached $2.1m, up 20% year-over-year.
Processing fee revenue was $1.5m, up 18% year-over-year.
Interest revenue from customer funds increased 26% year-over-year to $0.6m.
ARR stood at $8.2m, up 18% year-over-year.
Outlook and guidance
Targeting $10 million in ARR as the next growth milestone.
Plans to accelerate growth by capitalizing on the Gen 2.0 payroll engine and integrating acquired customers into a unified solution.
Latest events from PaySauce
- ARR up 17% to $8.7m, profitability and customer base expanded, supporting scalable growth.PYS
H1 202512 Jan 2026 - Revenue and profit rose, supporting global expansion and improved efficiency.PYS
H1 202619 Nov 2025 - Record ARR and robust processing fee growth achieved as Australian launch preparations advance.PYS
Q2 2026 TU19 Nov 2025 - Strong revenue and customer growth, improved profitability, and focus on Australian expansion.PYS
AGM 2025 Presentation28 Sep 2025 - Recurring revenue up 6% YoY, processing fees up 17%, and Australian launch nearing.PYS
Q1 2026 TU7 Sep 2025 - Recurring revenue up 19% YoY and customer base up 9%, driven by platform unification.PYS
Q2 2025 TU13 Jun 2025 - First net profit achieved, recurring revenue up 32%, and $10m ARR targeted for future growth.PYS
AGM 2024 Presentation13 Jun 2025 - Processing fee revenue surged 13% YoY in Q4 FY25, driven by 11% customer growth.PYS
Q4 2025 TU6 Jun 2025 - Double-digit growth in revenue, customers, and profitability, with strong cash flow and R&D investment.PYS
H2 20255 Jun 2025